| Product NDC: | 0713-0632 |
| Proprietary Name: | Fluticasone Propionate |
| Non Proprietary Name: | Fluticasone Propionate |
| Active Ingredient(s): | .05 mg/g & nbsp; Fluticasone Propionate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0713-0632 |
| Labeler Name: | GW Laboratories, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077168 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060531 |
| Package NDC: | 0713-0632-15 |
| Package Description: | 15 g in 1 TUBE (0713-0632-15) |
| NDC Code | 0713-0632-15 |
| Proprietary Name | Fluticasone Propionate |
| Package Description | 15 g in 1 TUBE (0713-0632-15) |
| Product NDC | 0713-0632 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fluticasone Propionate |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20060531 |
| Marketing Category Name | ANDA |
| Labeler Name | GW Laboratories, Inc |
| Substance Name | FLUTICASONE PROPIONATE |
| Strength Number | .05 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |